Shenzhen Salubris Pharmaceuticals Co., Ltd.: Not applicable (device, behavioral) study in Hypertension (1500 participants)
Shenzhen Salubris Pharmaceuticals Co., Ltd.: Not applicable (device, behavioral) study in Hypertension (1500 participants). Its enrollment of 1,500 is top-decile (96th percentile of 8,879 records). Dated 17 days ago, it is in the active follow-up window. Score 50/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 1,500 · 96th percentile of 8,879 ClinicalTrialStartPulse records · 18.8x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Shenzhen Salubris Pharmaceuticals Co., Ltd. |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | An Extension Trial of GW 906 in Participants With Essential Hypertension |
| NCT ID | NCT07879755 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Hypertension |
| Intervention types | drug |
| Target enrollment | 1500 |
| Site countries | China |
| Posted | 2026-10-19 |
| Planned start | 2026-06-12 |
| Event | Newly registered study |
| Event date | 2026-10-19 |
| enrollment percentile | 96th of 8,879 (median 80, 18.8x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Shenzhen Salubris Pharmaceuticals Co., Ltd.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Shenzhen Salubris Pharmaceuticals Co. + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-19
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Shenzhen Salubris Pharmaceuticals Co., Ltd. and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Shenzhen Salubris Pharmaceuticals Co., Ltd.'s enrollment: 96th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
50 / 100 Score
- Industry sponsor (buys outsourced services).
- 1500 participants planned.
What is the ClinicalTrialStartPulse record for Shenzhen Salubris Pharmaceuticals Co., Ltd.?
Shenzhen Salubris Pharmaceuticals Co., Ltd. registered a Not applicable (device, behavioral) study (NCT07879755) in Hypertension targeting 1500 participants, posted 2026-10-19.
How does Shenzhen Salubris Pharmaceuticals Co., Ltd. compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 1,500 is 18.8x the median of 80 across 8,879 records. It is 17 days old, still within a typical 45-day follow-up window.
Shenzhen Salubris Pharmaceuticals Co., Ltd. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | NONUS | 1,500 | 96th | 2026-10-19 |
| Galderma R&D | NONUS | 326 | 84th | 2026-11-02 |
| Galderma R&D | NONUS | 162 | 72nd | 2026-11-03 |
| A.M.I. Agency for Medical Innovations GmbH | NONUS | 100 | 60th | 2026-10-30 |
Related records
ClinicalTrialStartPulse: Not applicable (device, behavioral) ClinicalTrialStartPulse: Outside the US only
How to monitor Shenzhen Salubris Pharmaceuticals Co., Ltd. and peer not applicable (device, behavioral) records
Get new ClinicalTrialStartPulse records like Shenzhen Salubris Pharmaceuticals Co., Ltd. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.